SPSergey S. Panteleev

Sergey S. Panteleev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sergey S. Panteleev has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs

    by Nadia Anikeeva, Sergey Panteleev, Nicholas W. Mazzanti, Mizue Terai, Takami Sato, Yuri Sykulev


  • Supraspinal Mechanisms of Intestinal Hypersensitivity

    by Olga A. Lyubashina, Ivan B. Sivachenko, Sergey S. Panteleev

    Gut inflammation or injury causes intestinal hypersensitivity (IHS) and hyperalgesia, which can persist after the initiating pathology resolves, are often referred to somatic regions and exacerbated by psychological stress, anxiety or depression, suggesting the involvement of both the spinal cord and the brain. The supraspinal mechanisms of IHS remain to be fully elucidated, however, over the last decades the series of intestinal pathology-associated neuroplastic changes in the brain has been revealed, being potentially responsible for the phenomenon. This paper reviews current clinical and experimental data, including the authors’ own findings, on these functional, structural, and neurochemical/molecular changes within cortical, subcortical and brainstem regions processing and modulating sensory signals from the gut. As concluded in the review, IHS can develop and maintain due to the bowel inflammation/injury-induced persistent hyperexcitability of viscerosensory brainstem and thalamic nuclei and sensitization of hypothalamic, amygdala, hippocampal, anterior insular, and anterior cingulate cortical areas implicated in the neuroendocrine, emotional and cognitive modulation of visceral sensation and pain. An additional contribution may come from the pathology-triggered dysfunction of the brainstem structures inhibiting nociception. The mechanism underlying IHS-associated regional hyperexcitability is enhanced NMDA-, AMPA- and group I metabotropic receptor-mediated glutamatergic neurotransmission in association with altered neuropeptide Y, corticotropin-releasing factor, and cannabinoid 1 receptor signaling. These alterations are at least partially mediated by brain microglia and local production of cytokines, especially tumor necrosis factor α. Studying the IHS-related brain neuroplasticity in greater depth may enable the development of new therapeutic approaches against chronic abdominal pain in inflammatory bowel disease.


  • Open Access

    Effects of electromagnetic millimeter waves on the neuron activity of the spinal trigeminal nucleus of the rat

    by Сергей Степанович Пантелеев, Иван Борисович Сиваченко, Olga A. Lyubashina, Дмитрий Станиславович Медведев, Алексей Юрьевич Соколов

    The study examined the effects of continuous low-intensity electromagnetic millimeter waves (MMW; frequency 40 GHz, power density of 0.04 mW/cm2) on ongoing firing of the spinal trigeminal nucleus (STN) neurons and their responses to the electrical stimulation of the dura mater in neurophysiological experiments on anesthetized rats. It is known that local exposure of MMW to certain areas of the skin can have a systemic therapeutic effect in the treatment of various pathologies. In particular, it concerns the use of MMW to treat headache of different genesis, with migraine being the most common form. The mechanisms of migraine are not clear, but it is known that the STN plays a key role in the migraine pathogenesis, providing the primary processing of pain signals from the cranial vessels as well as the transmission of these signals to overlying brain structures, in particular, to the thalamus. Recently, it has been reported that the frequency-modulated MMW causes short-term inhibitory changes in both the background activity of STN neurons and their responses to electrical stimulation of the dura mater. We assumed that the use of MMW in the unmodulated mode will allow to increase the duration of the MMW inhibitory effect on the background and evoked activity of STN neurons and thereby confirm potential antinociceptive action of MMW in migraine. The results of the present study have showed that the exposure of the STN neurons’ cutaneous receptive fields to unmodulated MMW is accompanied by prolonged cumulative inhibition of both the background activity of these neurons and their dural electrostimulation-evoked responses. The data allow considering these effects as an evindence in favour of potential antimigraine action of a continuous low-intensity MMW. It is proposed that the action can be based on the activation of nervous and immune processes in the skin, which, through a chain of neuronal mechanisms, can lead to a decrease in the excitability of STN neurons involved in the pathogenesis of migraine. В нейрофизиологических экспериментах на наркотизированных крысах на модели мигрени изучалось влияние непрерывного низкоинтенсивного электромагнитного излучения миллиметрового диапазона (ЭМИ ММД; частота 40 ГГц, плотность мощности 0.04 мВт/см2) на фоновую и вызванную электрическим раздражением твердой мозговой оболочки активность нейронов спинального ядра тройничного нерва (СЯТН). Известно, что локальные воздействия ЭМИ ММД на определенные области кожных покровов могут сопровождаться системным терапевтическим эффектом при лечении разных патологий. В частности, это касается использования ЭМИ ММД для лечения головных болей разного генеза, одной из наиболее распространенных форм которых является мигрень, представляющая собой хроническое неврологическое заболевание. Характерный признак мигрени — эпизодические приступы пульсирующей головной боли разной интенсивности. Механизм возникновения ее недостаточно ясен, однако известно, что в патологии этого заболевания ключевую роль играет СЯТН, обеспечивающее первичную обработку болевых сигналов от сосудов мозговых оболочек и передачу этих сигналов в вышележащие структуры мозга, в частности в таламус. Ранее было показано, что воздействие частотно-модулированного ЭМИ ММД сопровождается кратковременными тормозными изменениями фоновой и вызванной электрической стимуляцией твердой мозговой оболочки активности нейронов СЯТН. Мы предположили, что использование немодулированного ЭМИ ММД позволит увеличить продолжительность тормозного влияния излучения на фоновую и вызванную активность нейронов СЯТН и тем самым подтвердит потенциальный антиноцицептивный эффект ЭМИ ММД в отношении мигрени. Результаты наших опытов показали, что воздействие немодулированного ЭМИ ММД на кожное рецептивное поле нейронов СЯТН сопровождается продолжительным и кумулятивным тормозным влиянием как на фоновую активность нейронов исследуемого ядра, так и на их реакции, вызванные электростимуляцией твердой мозговой оболочки. Полученные данные позволяют рассматривать продемонстрированные эффекты как свидетельство в пользу потенциального антимигренозного действия низкоинтенсивного...

  • The central effects of buspirone on abdominal pain in rats

    by S. S. Panteleev, I. B. Sivachenko, O. A. Lyubashina

    Background: Buspirone, a partial agonist of the 5‐HT1a receptor (5‐HT1aR), owing to potential antinociceptive properties may be useful in treatment of abdominal pain in IBS patients. The pain‐related effects of buspirone are mediated via the 5‐HT1aRs, specifically located within the ventrolateral medulla (VLM). The most animal studies of the 5‐HT1aR involvement in pain control have been carried out with somatic behavioral tests. The 5‐HT1aR contribution in visceral pain transmission within the VLM is unclear. The objective of our study was to evaluate the 5‐HT1aR contribution in abdominal pain transmission within the VLM.Methods: Using animal model of abdominal pain (urethane‐anaesthetized rats), based on the noxious colorectal distension (CRD) as pain stimulus we studied effects of buspirone (1.0‐4.0 mg kg−1, iv) on the CRD‐induced VLM neuron and blood pressure responses as markers of abdominal pain before and after the 5‐HT1aR blockade by antagonist, WAY 100,635.Results: The CRD induced a significant increase in VLM neuron activity up to 201.5 ± 18.0% and depressor reactions up to 68 ± 1.8% of baseline. Buspirone (1.0‐4.0 mg kg−1, iv) resulted in an inhibition of the CRD‐induced neuron responses which were changed inversely with dose increase and decreased depressor reactions directly with dose increase. These effects were antagonized by intracerebroventricular WAY 100,635.Conclusion: Buspirone exerts complex biphasic action on the pain‐related VLM neuron activity inversely depending on dose. The final effect of buspirone depends on the functional balance between of activation the pre‐ and postsynaptic 5‐HT1aRs in mediating pain control networks.